cu[64]-25%canf-comb
PeptideexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT02498379)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
NPR3 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 64-copper
Oral
No
Parenteral
No
Topical
No
Also known as
- cu[64]-25%canf-comb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02498379 | Early Phase 1 (Phase 1) | Oct 1, 2014 | Washington University in St. Louis |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2014 |
1 organizations
Page 1 / 1